Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Pediatric Hematology specialists at the Alabama Center for Childhood Cancer and Blood Disorders, a program of the University of Alabama at Birmingham (UAB) and Children’s of Alabama, diagnose and treat bleeding disorders and non-cancer blood diseases such as hemophilia, von Willebrand disease, sickle cell disease, thalassemia, and other anemias. The nationally recognized, federally funded Comprehensive Hemophilia Treatment Center provides care for more than 200 patients with bleeding disorders.
The Center provides care for more than 1000 infants, children and adolescent patients with sickle cell disease throughout the state of Alabama. UAB is a nationally recognized academic center conducting research to help prevent complications of disease and to find a cure. This research has led to reductions in life limiting strokes during childhood and painful events that previously limited patient’s lives.
Patients with rare blood disorders are also cared for at the Alabama Center for Childhood Cancer and Blood Disorders. With access to life-saving bone marrow transplantation, the Center offers patients the unique opportunity to be cured of their disease at an early age.
+myBinderRelated Content
-
Sylvia Benjamin, MB, BS, FRCP, FRCPathSylvia Benjamin is Consultant in Haemato...
-
Shelley Crary, MD, MSDr. Shelley Crary received her undergrad...
-
Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency DepartmentOBJECTIVE: The aim of this study was to ...
-
Cohen Children’s Medical Center Northwell HealthThe mission of the Sickle Cell Program a...
-
Access to Care, and Emergency Department Utilization for Adults and Adolescents With Sickle Cell Disease: Ascq-Me an...Measurement of access to care and utiliz...
-
Oxygen’s surprisingly complex journey through your body – Enda Butlerhttps://www.youtube.com/watch?v=GVU_zANt...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
